Failed Trial Results of Verubecestat in Alzheimer ' s Published Failed Trial Results of Verubecestat in Alzheimer ' s Published

Treatment with the BACE inhibitor verubecestat was not effective in slowing the clinical progression of mild to moderate Alzheimer ' s disease in a phase 3 trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news